Full-automatic Cell Banking – 原能细胞科技集团

We used the systematic cryopreservation technology and the self-developed automatic intelligent cellbank system to establish a complete system of cell banking, transportation, cryopreservation and preparation and facilitate the long-term preservation of precious cell biological resources for customers.

With the development and progress of life science and technology, the demand of human healthy life is becoming more and more vigorous. Unmodified and vigorous human cells will become an indispensable life and health resources. Preservation is not only a matter of personal value, but also of family and social value. We believe that powerful human cells have infinite possibilities in the application of our lives and health.

Perinatal Tissue-derived MSC

Dental Pulp MSC

Adult Adipose Derived MSC

Adult Immune Cells

Expectant cell therapy technology

Nowadays, cell therapy has been recognized as the most desirable biological therapy by the industry, and has been listed as an important industry in almost all countries of the world. With the sudden increase in the attention of all mankind, there is a continuous technological surprise.

However, this is just a glimpse of the potential of cells. A related report indicates that the global market for cell therapy is expected to grow at a compound annual rate of 23.27% between 2017 and 2021.

The clinical value of Immune Cells

At present, the top 25 biopharmaceutical companies in the world have developed 909 kinds of immunotherapy。 Most of them are targeted at non-small cell lung cancer, breast cancer, prostate cancer, ovarian cancer and colorectal cancer。 422 of them are undergoing phase I/II clinical trials, 273 are in II/III stage, and 146 are in IV phase。

The clinical value of MSC

By 2016, more than 5,800 stem cell clinical studies involving more than 140 different diseases have been registered with the National Institutes of Health。 Of the 10 stem cell drugs approved worldwide, nine are derived from mesenchymal stem cells。